Mraz Amerine & Associates’s Medtronic MDT Stock Holding History

Mraz Amerine & Associates’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,328	Closed	-$380K	–	160
2016 Q4	$380K	Sell	5,328 -4	-0.1%	-$314	0.12%	109
2016 Q3	$461K	Hold	5,332	–	–	0.16%	92
2016 Q2	$463K	Hold	5,332	–	–	0.16%	87
2016 Q1	$400K	Buy	+5,332	New	+$402K	0.15%	93
2015 Q1	–	Sell	-6,984	Closed	-$504K	–	151
2014 Q4	$504K	Hold	6,984	–	–	0.19%	86
2014 Q3	$433K	Buy	6,984 +106	+2%	+$6.74K	0.17%	89
2014 Q2	$439K	Hold	6,878	–	–	0.17%	86
2014 Q1	$423K	Hold	6,878	–	–	0.18%	83
2013 Q4	$395K	Hold	6,878	–	–	0.18%	80
2013 Q3	$366K	Hold	6,878	–	–	0.18%	83
2013 Q2	$354K	Buy	+6,878	New	+$340K	0.18%	84

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Mraz Amerine & Associates's MDT Position: Q1 2017 in Review

Mraz Amerine & Associates sold out of Medtronic (MDT) in Q1 2017, closing a stake of 5,328 shares — an estimated $380K sold.

Mraz Amerine & Associates first reported a position in MDT in Q2 2013 and held it in 11 quarters. The position peaked at $504K in Q4 2014. 1,284 funds tracked by Wall St. Rank hold MDT as of Q1 2017.

Mraz Amerine & Associates reported no remaining Medtronic position as of Q1 2017 after selling out during the quarter.
Mraz Amerine & Associates sold 5,328 Medtronic shares in Q1 2017, an estimated $380K.
Mraz Amerine & Associates first reported a position in Medtronic in Q2 2013 and held it in 11 quarters.
Mraz Amerine & Associates's Medtronic position peaked at $504K in Q4 2014.
1,284 funds tracked by Wall St. Rank held Medtronic as of Q1 2017.

Based on Mraz Amerine & Associates's 13F filing for Q1 2017, filed 5 May 2017.